Medtech

Citeline Study Feasibility

Bio-IT World Conference & Expo

30 Jul 2022

Citeline

Integrate your data to get the full picture

28 Jul 2022

Biomedtracker

Biomedtracker 2018 Early Outlook Report

28 Jul 2022

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 28 Jul 2022

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Trialtrove

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

01 Jul 2022

To highlight the growing importance of IO and especially IO combination trials within oncology clinical development, visual trends and key insights about the past 20+ years were compiled.

Citeline

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

30 Jun 2022

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient  

Citeline

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

27 Jun 2022

Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year. 

Citeline

Pharma R&D Annual Review 2022: Navigating the Landscape

27 Jun 2022

Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.